CHICAGO—Altris.AI has signed an agreement with Huvitz Co., Ltd. aimed at the development of customized deep learning solutions for retinal diseases detection unique for the Huvitz HOCT-1/1F device, an “all-in-one, PC-integrated 3D optical coherence tomography (OCT) and fundus camera. Altris.AI’s OCT and fundus algorithms have been trained using anonymized OCT retinal scans as well as fundus images collected during more than 12 years, and are able to detect more than 50 retinal diseases and conditions, the company said in a statement.

Currently, Altris.AI’s solution is available in web and mobile version for structural retina analysis. The model shows the high level of performance with multi-disease classification accuracy more than 96 percent, according to Altris.AI. Among the main retinal conditions which Altris.AI model can detect are
dry and wet age-related macular degeneration, diabetic retinopathy, degenerative myopia and retinitis pigmentosa.

Altris.AI’s technology will complement the Huvitz HOCT-1/1F by adding new features for diagnostic support and automatic retinal diseases detection on OCT scans or fundus images in combination or separately, which allows ophthalmologists and optometrists with basic knowledge to have a higher level of performance as an experienced retinal imaging specialist, Altris.AI said.